Bilah Samping Artikel

Telah diserahkan
Jun 19, 2022
Diterima
Jul 4, 2022
Diterbitkan
Jul 29, 2022
Download
Efikasi Terapi Plasma Konvalesen pada Pasien Covid-19: Sistematik Review dan Meta – Analisis
Statistic
Read Counter : 900 Download : 863

Isi Artikel Utama

Abstrak

Pendahuluan: COVID-19 berkembang menjadi pandemik global dan sampai saat ini belum ditemukan terapi yang definitif. Mortalitas COVID-19 relatif tinggi, terutama pada pasien yang memiliki komorbid. Terapi plasma konvalesen yang sudah banyak dilakukan belum diakui secara universal mampu meningkatkan kesembuah pasien COVID-19. Tujuan: Penelitian ini bertujuan mengetahui efikasi terapi plasma konvalesen pada pasien COVID-19. Metode: Desain peneitian adalah systematic Review dan Meta Analisa. Data diperoleh dari database jurnal elektronik PubMed, Cochrane Library, ProQuest, SpringerLink, ScienceDirect, Scopus, dan Google Scholar dengan Medical Subject Heading (Mesh) “Effication Plasma Convalescent Therapy, SARS CoV-2”. Data dianalisis menggunakan pedoman PRISMA. Hasil: Hasil penelitian : 1) Tidak ada perbedaan risiko atau tingkat kematian pasien Covid-19 yang diberikan terapi plasma konvalesen dengan yang diberikan terapi standar (OR:1,004;CI; 0,817 - 1,234;p= 0,970), 2) Tingkat kesembuhan pasien COVID-19 yang diberikan terapi plasma konvalesen tidak berbeda dengan yang diberikan terapi standar (OR:0,996;CI:0,810 – 1,224;p=0,970). Kesimpulan: terapi plasma konvalesen tidak memberikan efikasi yang cukup baik dalam proses penyembuhan pasien COVID-19 dengan gejala sedang sampai berat.

Kata Kunci

COVID - 19 Efikasi Terapi Plasma Konvalesen

Rincian Artikel

##submission.license.cc.by-sa4.footer##

Before submission,

  • You have to make sure that your paper is prepared using the JKH Paper Template, has been carefully proofread and polished, and conformed to the author guidelines
  • If the manuscript submitted is not appropriate with the guidelines or written in a different format, it will BE REJECTED by the editors before further reviewed. The editors will only accept the manuscripts which meet the assigned format.

Published by Sekolah Tinggi Ilmu Kesehatan RS Husada

Jl. Mangga Besar Raya No.137-139, Jakarta Pusat, 10730 - Indonesia
Email: lppm@stikesrshusada.ac.id
Web: https://ejournal.stikesrshusada.ac.id/index.php/jkh/

Creative Commons License
JKH is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright ©Sekolah Tinggi Ilmu Kesehatan RS Husada
All right reserved

##submission.howToCite##
Diyono, D., & Sriwiyati, L. (2022). Effication of Convalence Plasma Therapy in Covid-19 Patients: Systemic Review and Meta – Analysis. Jurnal Kesehatan Holistic, 6(2), 81-91. https://doi.org/10.33377/jkh.v6i2.140
##submission.howToCite.downloadCitation##
##plugins.generic.citationStyleLanguage.download.ris##
##plugins.generic.citationStyleLanguage.download.bibtex##

References

  1. Aeni, N. (2021). Pandemi COVID-19: Dampak Kesehatan, Ekonomi, & Sosial. Jurnal Litbang: Media Informasi Penelitian, Pengembangan Dan IPTEK, 17(1), 17–34. https://doi.org/10.33658/jl.v17i1.249
  2. Agarwal, A., Mukherjee, A., Kumar, G., Chatterjee, P., & Bhatnagar, T. (2020). Convalescent plasma in the management of moderate covid-19 in adults in India : open label phase II multicentre randomised controlled trial ( PLACID Trial ). 1–10. https://doi.org/10.1136/bmj.m3939
  3. Alqahtani, M., Abdulrahman, A., Almadani, A., Alali, S. Y., Mahmood, A., Zamrooni, A., Hejab, A. H., Conroy, R. M., Wasif, P., Otoom, S., Atkin, S. L., & Abduljalil, M. (2021). Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID ‑ 19 disease. Scientific Reports, 1–8. https://doi.org/10.1038/s41598-021-89444-5
  4. Bank Indonesia. (2020). Krisis Kemanusiaan COVID-19 dan Implikasinya pada Tatanan Perekonomian Global. 2020, 20. https://www.bi.go.id/id/publikasi/laporan/Documents/3_LPI2020_BAB1.pdf
  5. Berg, K. Van Den, Glatt, T. N., Vermeulen, M., Little, F., Swanevelder, R., Barrett, C., Court, R., Bremer, M., Nyoni, C., Swarts, A., Mmenu, C., Crede, T., Kritzinger, G., & Naude, J. (2022). Convalescent plasma in the treatment of moderate to severe COVID ‑ 19 pneumonia : a randomized controlled trial ( PROTECT ‑ Patient Trial ). Scientific Reports, 1–11. https://doi.org/10.1038/s41598-022-06221-8
  6. Callum, J., Jamula, E., Cook, R., Heddle, N. M., Tinmouth, A., Zeller, M. P., Amorim, L., Loftsgard, K. C., Carl, R., Cushing, M. M., Daneman, N., Devine, D. V, Dumaresq, J., Fergusson, D. A., Gabe, C., Glesby, M. J., Li, N., Liu, Y., Mcgeer, A., … Arnold, D. M. (2021). Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. 27(November). https://doi.org/10.1038/s41591-021-01488-2
  7. Diyono, & Kristanto, B. (2021). Faktor Comorbid Covid-19 di Indonesia Scopyng Review. Jurnal Ilmu Kesehatan, 9(1), 51–59.
  8. Donnell, M. R. O., Grinsztejn, B., Cummings, M. J., Justman, J. E., Lamb, M. R., Eckhardt, C. M., Philip, N. M., Cheung, Y. K., Gupta, V., João, E., Pilotto, J. H., Diniz, M. P., Cardoso, S. W., Abrams, D., Rajagopalan, K. N., Borden, S. E., Wolf, A., Sidi, L. C., Vizzoni, A., … Schwartz, J. (2021). A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. 2019(1), 1–9.
  9. Holm, K., Lundgren, M. N., Kragh, J. K., Ljungquist, O., Böttiger, B., Wikén, C., Öberg, J., Fernström, N., Rosendal, E., Överby, A. K., Byström, J. W., Forsell, M., Olsson, M. L., & Rasmussen, M. (2021). Convalescence plasma treatment of COVID ‑ 19 : results from a prematurely terminated randomized controlled open ‑ label study in Southern Sweden. BMC Research Notes, 1–5. https://doi.org/10.1186/s13104-021-05847-7
  10. Ika. (2020). Mengenal Terapi Konvalesen Sebagai Alternatif Pengobatan Covid-19. Universitas Gajah Mada, 2. https://ugm.ac.id/id/berita/19645-mengenal-terapi-konvalesen-sebagai-alternatif-pengobatan-covid-19
  11. Indraswara, Y. (2021). Plasma konvalesen untuk COVID-19. OSF Preprints, 1(19), 3. https://osf.io/s25m3/
  12. Janiaud, P., Axfors, C., Schmitt, A. M., Gloy, V., Ebrahimi, F., Hepprich, M., Smith, E. R., Haber, N. A., Khanna, N., Moher, D., Goodman, S. N., Ioannidis, J. P. A., & Hemkens, L. G. (2021). Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis. JAMA - Journal of the American Medical Association, 325(12), 1185–1195. https://doi.org/10.1001/jama.2021.2747
  13. Kemdikbud. (2017). Kamus Besar Bahasa Indonesia. https://kbbi.web.id/mitra.
  14. Klassen, S. A., Senefeld, J. W., Johnson, P. W., Carter, R. E., Wiggins, C. C., Shoham, S., Grossman, B. J., Henderson, J. P., Musser, J., Salazar, E., Hartman, W. R., Bouvier, N. M., Liu, S. T. H., Pirofski, L. anne, Baker, S. E., van Helmond, N., Wright, R. S., Fairweather, D. L., Bruno, K. A., … Joyner, M. J. (2021). The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clinic Proceedings, 96(5), 1262–1275. https://doi.org/10.1016/j.mayocp.2021.02.008
  15. Li, L., Zhang, W., Hu, Y., Tong, X., Zheng, S., Yang, J., & Kong, Y. (2020). Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial. 324(5), 460–470. https://doi.org/10.1001/jama.2020.10044
  16. Liege, U. of. (2020). Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation. ClinicalTrials.Gov.
  17. Mardian, Y. (2020). Uji Klinis Pemberian Plasma Konvalesen Sebagai Terapi Tambahan Corona Virus Disease 19 (COVID-19)-PLASENTER. Angewandte Chemie International Edition, 6(11), 951–952., 1.
  18. Maulana, M. S. (2020). Efektivitas Efikasi Pemberian Terapi Konvalesen Plasma Pada Pasien Covid-19 : Evidence Based Case Report. Jurnal Kedokteran Dan Kesehatan : Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya, 7(3), 7–14. https://doi.org/10.32539/jkk.v7i3.12297
  19. PDPI, PERKI, PAPDI, PERDATIN, & IDAI. (2020). Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020. In Pedoman Tatalaksana COVID-19. https://www.papdi.or.id/download/983-pedoman-tatalaksana-covid-19-edisi-3-desember-2020
  20. PMI. (2021). Procurement Convalescent Plasma for Covid-19 in Indonesia Red Cross. Webinar Pds Patklin Pmi Roche. https://www.pdspatklin.or.id/assets/files/pdspatklin_2021_04_18_20_55_26.pdf
  21. Ratnadi, P. C., & Sujana, I. B. G. (2017). Prinsip Dasar Farmakologi. Medical Education, Pp. 1-86. https://simdos.unud.ac.id/uploads/file_penelitian_1_dir/f7b9df04ff99e9d55d73e117e78f7d61.pdf
  22. Rejeki, M. S., Sarnadi, N., Wihastuti, R., Fazharyasti, V., Samin, W. Y., Yudhaputri, F. A., Johar, E., Nurainy, N., Bachtiar, N. S., & Muljono, D. H. (2021). Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries. EClinicalMedicine, 36, 100931. https://doi.org/10.1016/j.eclinm.2021.100931
  23. Sekine, L., Arns, B., Fabro, B. R., Cipolatt, M. M., Machado, R. R. G., Durigon, E. L., Parolo, E., Pellegrini, J. A. S., Viana, M. V, Schwarz, P., Lisboa, T. C., Dora, J. M. S., Portich, J. P., Paz, A. A., Silla, L., Balsan, A. M., Schirmer, F., Franz, J. P. M., Luciana, M., … Rosa, R. G. (2022). Convalescent plasma for COVID-19 in hospitalised patients : an open-label , randomised clinical trial. April 2021. https://doi.org/10.1183/13993003.01471-2021
  24. Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 24, 91–98. https://doi.org/10.1016/j.jare.2020.03.005
  25. Simonovich, L. D. B., Pratx, P. Scibona, M. V., Beruto, M. G. V., C. Vázquez, N. Savoy, D. H., Giunta, L.G. Pérez, M. . L., Sánchez, A. V., Gamarnik, D.S., Ojeda, D. M., Santoro, P. J., Camino, S. Antelo, K., Rainero, G. P. V., E.A. Miyazaki, W. Cornistein, O.A. Trabadelo, F.M. Ross, M. Spotti, G. F., W.E. Scordo, M.H. Losso, I. Ferniot, P.E. Pardo, E. Rodriguez, P. R., J. Pasquali, N.A. Fuentes, M. Esperatti, G.A. Speroni, E.C. Nannini, A. M., & H.G. Michelangelo, D. Follmann, H.C. Lane, and W. H. B. (2021). A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. 619–629. https://doi.org/10.1056/NEJMoa2031304
  26. Sola, C., Ramos-martínez, A., Muñez-rubio, E., Ruiz-antorán, B., Molina, R. M. De, Torres, F., Fernández-cruz, A., Calderón-parra, J., Payares-herrera, C., Santiago, A. D. De, Romera-martínez, I., Pintos, I., Lora-tamayo, J., Mancheño-losa, M., Paciello, M. L., Vidán-estévez, J., Nuñez-orantos, M. J., Saez-serrano, M. I., Porras-leal, M. L., … Rubio-batllés, M. (2021). A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. 131(20), 1–10.
  27. Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G., Nainggolan, L., Nelwan, E. J., Chen, L. K., Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, C. O. M., & Yunihastuti, E. (2020). Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia, 7(1), 45. https://doi.org/10.7454/jpdi.v7i1.415
  28. Unhale, S. S., Ansar, Q. B., Sanap, S., Thakhre, S., & Wadatkar, S. (2020). a Review on Corona Virus ( Covid-19 ). World Journal of Pharmaceutical, 6(4), 109–115.
  29. Vegivinti, C. T. R., Pederson, J. M., Saravu, K., Gupta, N., Evanson, K. W., Kamrowski, S., Schmidt, M., Barrett, A., Trent, H., Dibas, M., Reierson, N. L., Mikoff, N., Pisipati, S., Joseph, B. A., Selvan, P. T., Dmytriw, A. A., Pulakurthi, Y. S., Keesari, P. R., Sriram, V., … Hassan, A. E. (2021). Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis. Journal of Clinical Apheresis, 36(3), 470–482. https://doi.org/10.1002/jca.21881
  30. Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. International Journal of Infectious Diseases, 94, 91–95. https://doi.org/10.1016/j.ijid.2020.03.017.